421 |
Non-compliance with chemotherapy in the oncology patient with a good prognosisBenjamin, Ruth Valerie Nona 31 October 2006 (has links)
Student Number : 9411363J -
PhD thesis -
School of Medicine -
Faculty of Health Sciences / This study on non-compliance with chemotherapy in the oncology patient with a good
prognosis was done in the Johannesburg Hospital in South Africa.
114 compliant and 33 non compliant oncology patients with a good prognosis showed
significant differences (at the 5% level) on the MCMI2 on the following scales:
Disclosure, Debasement, Avoidance, Passive Aggressive, Self-defeating, Schizotypal,
Anxiety, Dysthymia, Alcohol Dependence and Major Depression.
In a Linear Discriminant Function Analysis . two variables, Debasement and Schizotypal
were selected that linearly affected compliance significantly. A linear discriminant model
was constructed from the two variables which could predict non compliance in these
patients 72.5% of the time.
The next step was to construct a treatment model , an intervention which would have some
impact on improving compliance. After trial and error with various methods, a Medical
Trauma Debriefing Model was worked out and used, based on the Wits Trauma
Intervention Model, which up to this time had been used for trauma debriefing of people
who had experienced trauma due to violence and abuse on a criminal or political level.
This is in accordance with recent studies which are beginning to show the link between
PTSD and medical non-compliance.
It is suggested that Medical Trauma Debriefing, as a preventative measure, be incorporated
automatically and routinely into the treatment of certain medical and surgical conditions,
especially in Oncology.
|
422 |
Defining biological properties of the leukaemic stem cell in Hoxa9Meis1-induced leukaemiaAustin, Pamela M. January 2003 (has links)
No description available.
|
423 |
The role of the androgen receptor CAG repeat polymorphism in the AR-T877A prostate cancer somatic mutant /Southwell, Jason M. January 2006 (has links)
No description available.
|
424 |
Aspects of insulin-like growth factor physiology in cancerLevitt, Randy J. January 2006 (has links)
No description available.
|
425 |
Regulation of the mouse DNA methyltransferase gene expressionRouleau, Julie January 1995 (has links)
No description available.
|
426 |
Antisense inhibition of methylenetetrahydrofolate reductase as a cancer treatment and a pharmacogenetic study to examine the effects of a common polymorphismSekhon, Jaspreet. January 2001 (has links)
No description available.
|
427 |
Protein kinase C and growth regulation in malignant gliomasBaltuch, Gordon Hirsh January 1995 (has links)
No description available.
|
428 |
Characterization and functional studies of the mouse biliary glycoprotein (Bgp) genesNédellec, Patrick January 1995 (has links)
No description available.
|
429 |
Gene expression profile in human prostate cancer cell linesTrudel, Nathalie. January 2000 (has links)
No description available.
|
430 |
The regulation of patathyroid hormone related peptide (PTHRP) gene expression by androgens in prostate cancer /Pizzi, Helena. January 2001 (has links)
No description available.
|
Page generated in 0.0529 seconds